FDA Approves First Non-Opioid Painkiller in Over Two Decades
- The U.S. Food and Drug Administration approved Vertex Pharmaceuticals' Journavx, the first new non-opioid painkiller in over 20 years, for short-term pain following surgery or injuries.
- Journavx showed more relief than a placebo in studies but did not outperform a common opioid-acetaminophen combination pill.
- Vertex's drug works by blocking proteins that trigger pain signals, offering a different approach than traditional opioids.
- Experts note that while the drug shows promise, its modest effectiveness and lengthy development process highlight the challenges in pain management.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left21Leaning Right8Center76Last UpdatedBias Distribution72% Center
Bias Distribution
- 72% of the sources are Center
72% Center
L 20%
C 72%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
